92 results on '"Bouvier, Nancy"'
Search Results
52. BIOM-56. THE INTEGRATION OF A LIQUID BIOPSY PROGRAM INTO THE CARE OF PEDIATRIC BRAIN TUMOR PATIENTS
53. KIT as a Therapeutic Target in Metastatic Melanoma
54. COVID-19 in Children With Cancer in New York City
55. Abstract 1515: Tracking the origins and drivers of metastatic expansion in osteosarcoma
56. Abstract B70: Clonal evolution of chemotherapy-resistant rhabdomyosarcoma via multifocal genomic analysis of pretreatment and treatment-resistant autopsy specimens
57. Prospective agnostic germline testing in pediatric cancer patients.
58. 11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood
59. Author Correction: Tumour lineage shapes BRCA-mediated phenotypes
60. Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARAfusion–associated myeloid neoplasm
61. Abstract 1752: BRCA-mediated tumorigenesis is origin and cell-type dependent
62. Genomic and Transcriptomic Characterization of Papillary Microcarcinomas With Lateral Neck Lymph Node Metastases
63. EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
64. Somatic genetic alterations in synchronous and metachronous low-grade serous tumours and high-grade carcinomas of the adnexa
65. A recurrent novel MGA–NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma
66. Next Generation Sequencing of Urine Specimens: A Novel Platform for Genomic Analysis in Patients with Non-Muscle Invasive Urothelial Carcinoma Treated with Bacillus Calmette-Guerin
67. Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
68. DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma
69. AKT Inhibition in Solid Tumors With AKT1 Mutations
70. Abstract CT001: Neratinib in HER2 or HER3 mutant solid tumors: SUMMIT, a global, multi-histology, open-label, phase 2 "basket" study
71. Correlation of benefit from immune checkpoint inhibitors with next gen sequencing (NGS) profiles in esophagogastric cancer (EGC) patients.
72. Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guérin
73. Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma
74. Abstract 298: Amplification of mutant ERBB2 drives resistance to the irreversible kinase inhibitor neratinib in ERBB2-mutated breast cancer patients
75. Emergence of RTK/RAS/PI3K pathway alterations in trastuzumab-refractory HER2-positive esophagogastric (EG) tumors.
76. Distinctive Genomic Alterations in Testicular Diffuse Large B Cell Lymphoma
77. Integrating technology to support data management abstraction of adverse events (AE) and concomitant medications (ConMed) from the electronic health record (EHR) to sponsor electronic data capture (EDC) systems using design thinking (DT) methodology.
78. Clonal hematopoiesis in survivors of childhood cancer.
79. Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway
80. Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer
81. Identification of efficacy biomarkers in a large metastatic renal cell carcinoma (mRCC) cohort through next generation sequencing (NGS): Results from RECORD-3.
82. Association of somatic mutations in DNA damage repair (DDR) genes with efficacy of platinum-based chemotherapy in advanced urothelial carcinoma.
83. Hematopoietic Stem Cell Origin of BRAF V600E Mutations in Hairy Cell Leukemia
84. Ramp rat roose: Eric Veal, day shift line service supervisor for Banyan Air Service
85. Mutations inGNA11in Uveal Melanoma
86. Humoral and Cellular Immune Responses in Children Given Annual Immunization With Trivalent Inactivated Influenza Vaccine
87. Hematopoietic Stem Cell Origin of BRAFV600E Mutations in Hairy Cell Leukemia.
88. Ramp Rats
89. Next-Generation Sequencing Analysis of Angiosarcomas Reveals Common MAPK Pathway Alterations and MYC Amplifications
90. Ramp Rat Roose.
91. Tech Forum.
92. A recurrent novel MGA-NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.